Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Work In Process (2023 - 2026)

Adagio Medical Holdings has reported Work In Process over the past 4 years, most recently at $203000.0 for Q1 2026.

  • Quarterly Work In Process rose 93.33% to $203000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $203000.0 through Mar 2026, up 93.33% year-over-year, with the annual reading at $163000.0 for FY2025, 57.99% down from the prior year.
  • Work In Process was $203000.0 for Q1 2026 at Adagio Medical Holdings, up from $163000.0 in the prior quarter.
  • Over five years, Work In Process peaked at $509000.0 in Q3 2024 and troughed at $82000.0 in Q3 2025.
  • The 4-year median for Work In Process is $180000.0 (2023), against an average of $217375.0.
  • Year-over-year, Work In Process skyrocketed 96.95% in 2024 and then plummeted 83.89% in 2025.
  • A 4-year view of Work In Process shows it stood at $197000.0 in 2023, then skyrocketed by 96.95% to $388000.0 in 2024, then tumbled by 57.99% to $163000.0 in 2025, then increased by 24.54% to $203000.0 in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Work In Process are $203000.0 (Q1 2026), $163000.0 (Q4 2025), and $82000.0 (Q3 2025).